Rob Brierley


Rob Brierley is Editor-in-Chief of The Lancet Gastroenterology & Hepatology, having launched the journal in 2016 and establishing it as the world-leading journal for gastroenterology and hepatology research and an internationally trusted source of clinical, public health, and global health knowledge. The journal’s advocacy for the elimination of viral hepatitis reflects Rob’s long-standing interest in viral hepatitis, both in terms of clinical management and public health. Rob has worked across The Lancet group of journals since 2004, including The Lancet Infectious Diseases, The Lancet, and The Lancet Oncology. Rob holds a master’s in molecular and cellular biochemistry from the University of Oxford and a master’s in clinical oncology from the University of Birmingham.